Journal of Neurochemistry

Article	Citations
A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain	150
Microglial phagocytosis of neurons in neurodegeneration, and its regulation	117
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease	90
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease	88
Chrono‐nutrition: From molecular and neuronal mechanisms to human epidemiology and timed feeding patterns	86
Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases	80
Role of sphingolipid metabolism in neurodegeneration	64
Exosomes in Parkinson disease	61
Microbiota‐gut‐brain axis as a regulator of reward processes	59
STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies	55
Presynaptic dysfunction in neurodevelopmental disorders: Insights from the synaptic vesicle life cycle	52
Amyloid‐β oligomers in cellular models of Alzheimer’s disease	49
Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer’s disease	48
Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies	47
Protective actions of exercise‐related FNDC5/Irisin in memory and Alzheimer’s disease	45
Astrocytes are HIV reservoirs in the brain: A cell type with poor HIV infectivity and replication but efficient cell‐to‐cell viral transfer	44
Disorders of synaptic vesicle fusion machinery	43
Pannexin‐1 in the CNS: Emerging concepts in health and disease	42
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD	42
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance	42
Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease	41
The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders	41
Viral infection and smell loss: The case of COVID‐19	40
Direct dopamine terminal regulation by local striatal microcircuitry	40
Acute pharmacological inhibition of matrix metalloproteinase‐9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice	39

The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease	39
Emerging role of PARP‐1 and PARthanatos in ischemic stroke	39
MicroRNA‐22‐3p alleviates spinal cord ischemia/reperfusion injury by modulating M2 macrophage polarization via IRF5	38
Receptor for advanced glycation end products up‐regulation in cerebral endothelial cells mediates cerebrovascular‐related amyloid β accumulation after Porphyromonas gingivalis infection	37
24S‐hydroxycholesterol: Cellular effects and variations in brain diseases	37
Ferroptosis: An emerging therapeutic target in stroke	37
Mislocalisation of TDP‐43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex	36
Muscone suppresses inflammatory responses and neuronal damage in a rat model of cervical spondylotic myelopathy by regulating Drp1‐dependent mitochondrial fission	36
The neurodevelopmental spectrum of synaptic vesicle cycling disorders	36
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy	35
Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species	35
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+	34
Addiction‐related neuroadaptations following chronic nicotine exposure	34
Sirtuin 3 is required for the protective effect of Resveratrol on Manganese‐induced disruption of mitochondrial biogenesis in primary cultured neurons	34
The role of neuroimaging in Parkinson’s disease	34
Amyloid processing in COVID‐19‐associated neurological syndromes	34
Occludin degradation makes brain microvascular endothelial cells more vulnerable to reperfusion injury in vitro	33
Epigenetic restoration of voltage‐gated potassium channel Kv1.2 alleviates nerve injury‐induced neuropathic pain	33
Regulators of cholinergic signaling in disorders of the central nervous system	32
Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease	32
The multi‐functional RNA‐binding protein G3BP1 and its potential implication in neurodegenerative disease	31
The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells	31
The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)	30
Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5	30
Toll‐like receptor 2 activation and up‐regulation by high mobility group box‐1 contribute to post‐operative neuroinflammation and cognitive dysfunction in mice	30
Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll‐like Receptor 4	30
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids	29
Neurochemistry of the Kölliker‐Fuse nucleus from a respiratory perspective	28
Neurobiology of alcohol seeking behavior	28
Glucocorticoid‐mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis	28
Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA1 receptor	28
The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease	28
MicroRNA‐3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease	27
Hippocampal hyperactivity in a rat model of Alzheimer’s disease	27
Erythropoietin and derivatives: Potential beneficial effects on the brain	26
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation	26
Ponesimod protects against neuronal death by suppressing the activation of A1 astrocytes in early brain injury after experimental subarachnoid hemorrhage	26
Neuromuscular junction‐on‐a‐chip: ALS disease modeling and read‐out development in microfluidic devices	26
What works and what does not work in Alzheimer’s disease? From interventions on risk factors to anti‐amyloid trials	26
Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings	26
GABAergic mechanisms in the suprachiasmatic nucleus that influence circadian rhythm	25
Synaptophysin‐dependent synaptobrevin‐2 trafficking at the presynapse‐Mechanism and function	25
Sex differences in the neurochemistry of frontal cortex: Impact of early life stress	25
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing	25
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders	25
Circuit selectivity in drug versus natural reward seeking behaviors	25
Mechanisms of neuronal survival safeguarded by endocytosis and autophagy	25
Sex‐dependent pronociceptive role of spinal α5‐GABAA receptor and its epigenetic regulation in neuropathic rodents	24
The axonal endolysosomal and autophagic systems	24
Molecular insights into psychedelic drug action	24

STING mediates neuroinflammatory response by activating NLRP3‐related pyroptosis in severe traumatic brain injury	24
Microglia‐dependent remodeling of neuronal circuits	24
Treating disorders across the lifespan by modulating cholinergic signaling with galantamine	23
Water‐soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7‐nAChR dysfunction	23
Cholinergic transmission in C. elegans: Functions, diversity, and maturation of ACh‐activated ion channels	23
Advances in understanding meso‐cortico‐limbic‐striatal systems mediating risky reward seeking	22
DJ‐1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons	22
A balancing act: the role of pro‐ and anti‐stress peptides within the central amygdala in anxiety and alcohol use disorders	22
SUMOylation of synaptic and synapse‐associated proteins: An update	22
To Ub or not to Ub: Regulation of circadian clocks by ubiquitination and deubiquitination	22
BDNF deficiency and enriched environment treatment affect neurotransmitter gene expression differently across ages	22
It’s more than just interoception: The insular cortex involvement in alcohol use disorder	22
Distinct alpha‐Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH‐SY5Y cells	22
Inhibiting Brd4 alleviated PTSD‐like behaviors and fear memory through regulating immediate early genes expression and neuroinflammation in rats	22
Three‐finger proteins from snakes and humans acting on nicotinic receptors: Old and new	22
SLC6 transporter oligomerization	22
Iron, ferroptosis, and ischemic stroke	21
Transcriptomic, peptidomic, and mass spectrometry imaging analysis of the brain in the ant Cataglyphis nodus	21
Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice	21
Long non‐coding RNAs in motor neuron development and disease	21
Tetanus and tetanus neurotoxin: From peripheral uptake to central nervous tissue targets	21
Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease	20
Sex‐specific alterations in NAD+ metabolism in 3xTg Alzheimer’s disease mouse brain assessed by quantitative targeted LC‐MS	20
Revisiting the proteolytic processing of cell adhesion molecule L1	20
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP‐43‐related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)	20
Vitamin C regulates Schwann cell myelination by promoting DNA demethylation of pro‐myelinating genes	20
Involvement of the Hsp70/TLR4/IL‐6 and TNF‐α pathways in delayed‐onset muscle soreness	20
Progranulin in neurodegenerative dementia	20
Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults	19
Diverse GABAergic neurons organize into subtype‐specific sublaminae in the ventral lateral geniculate nucleus	19
Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo	19
Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK‐3β in 3xTg‐AD mice	19
Cathepsin B inhibition blocks neurite outgrowth in cultured neurons by regulating lysosomal trafficking and remodeling	19
Docosahexaenoic acid protection against palmitic acid‐induced lipotoxicity in NGF‐differentiated PC12 cells involves enhancement of autophagy and inhibition of apoptosis and necroptosis	19
An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington’s disease caudate nucleus	18
MECP2 and the biology of MECP2 duplication syndrome	18
The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration	18
Criss‐crossing autism spectrum disorder and adult neurogenesis	18
Subsecond spontaneous catecholamine release in mesenteric lymph node ex vivo	18
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis	18
Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse	18
Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus	18
Central sympathetic nerve activation in subarachnoid hemorrhage	18
Wolfberry‐derived zeaxanthin dipalmitate delays retinal degeneration in a mouse model of retinitis pigmentosa through modulating STAT3, CCL2 and MAPK pathways	17
The neurochemistry of social reward during development: What have we learned from rodent models?	17
A neurodegeneration gene, WDR45, links impaired ferritinophagy to iron accumulation	17
Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission — The essential roles of astrocytes	17
Dopamine promotes the neurodegenerative potential of β‐synuclein	17
Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get	17
Role of Ten eleven translocation‐2 (Tet2) in modulating neuronal morphology and cognition in a mouse model of Alzheimer's disease	17
Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity	17
Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging	17
Orexins (hypocretins): The intersection between homeostatic and hedonic feeding	17
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis	16
Artemisinin inhibits TLR4 signaling by targeting co‐receptor MD2 in microglial BV‐2 cells and prevents lipopolysaccharide‐induced blood–brain barrier leakage in mice	16
Emodin inhibits aggregation of amyloid‐β peptide 1–42 and improves cognitive deficits in Alzheimer's disease transgenic mice	16
Pridopidine reduces mutant huntingtin‐induced endoplasmic reticulum stress by modulation of the Sigma‐1 receptor	16
Variability of mitochondrial energy balance across brain regions	16
Is there a role for the p75 neurotrophin receptor in mediating degeneration during oxidative stress and after hypoxia?	16
Extracellular vesicles containing the transferrin receptor as nanocarriers of apotransferrin	16
Substrate reduction therapy using Genz‐667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease	16
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease	16
Potential crosstalk between sonic hedgehog‐WNT signaling and neurovascular molecules: Implications for blood–brain barrier integrity in autism spectrum disorder	16
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies	16
The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view	16
Activation of neuronal Ras‐related C3 botulinum toxin substrate 1 (Rac1) improves post‐stroke recovery and axonal plasticity in mice	16
Ganglioside GD3 regulates dendritic growth in newborn neurons in adult mouse hippocampus via modulation of mitochondrial dynamics	16
Investigating the molecular mechanisms of learning and memory using Caenorhabditis elegans	16
Truncating mutations in SHANK3 associated with global developmental delay interfere with nuclear β‐catenin signaling	16
Fluid metabolic pathways after subarachnoid hemorrhage	15
CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer’s disease‐protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion	15
A multi‐level assessment of the bidirectional relationship between aging and the circadian clock	15
Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen‐specific glycopolymer	15
Regional and sex differences in spontaneous striatal dopamine transmission	15
Interrelations of Alzheimer´s disease candidate biomarkers neurogranin, fatty acid‐binding protein 3 and ferritin to neurodegeneration and neuroinflammation	15
Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease	15
LRRK2 at the pre‐synaptic site: A 16‐years perspective	15
Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis	15
Missense mutations in CASK, coding for the calcium‐/calmodulin‐dependent serine protein kinase, interfere with neurexin binding and neurexin‐induced oligomerization	15
Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression	15

A ketogenic diet differentially affects neuron and astrocyte transcription	15
The finger loop as an activation sensor in arrestin	15
HDAC2 (Histone deacetylase 2): A critical factor in environmental enrichment‐mediated stroke recovery	14
Zinc induces reactive astrogliosis through ERK‐dependent activation of Stat3 and promotes synaptic degeneration	14
The FGF2‐induced tanycyte proliferation involves a connexin 43 hemichannel/purinergic‐dependent pathway	14
Neurosteroids: A novel promise for the treatment of stroke and post‐stroke complications	14
SynaptoPAC, an optogenetic tool for induction of presynaptic plasticity	14
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies	14
Molecular targets of psychedelic‐induced plasticity	14
The 2022 Lady Estelle Wolfson lectureship on neurofilaments	14
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR	14
MicroRNA‐124‐3p attenuates the development of nerve injury–induced neuropathic pain by targeting early growth response 1 in the dorsal root ganglia and spinal dorsal horn	14
The penalty of stress ‐ Epichaperomes negatively reshaping the brain in neurodegenerative disorders	14
Olfactory bulb‐targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice	14
Psychedelic‐inspired approaches for treating neurodegenerative disorders	14
Phosphorylation of Syntaxin‐1a by casein kinase 2α regulates pre‐synaptic vesicle exocytosis from the reserve pool	14
Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking	14
MEC17‐induced α‐tubulin acetylation restores mitochondrial transport function and alleviates axonal injury after intracerebral hemorrhage in mice	13
Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination	13
Activation of silent information regulator 1 exerts a neuroprotective effect after intracerebral hemorrhage by deacetylating NF‐κB/p65	13
PKC‐ and PKA‐dependent phosphorylation modulates TREK‐1 function in naïve and neuropathic rats	13
Human immunodeficiency virus‐1/simian immunodeficiency virus infection induces opening of pannexin‐1 channels resulting in neuronal synaptic compromise: A novel therapeutic opportunity to prevent Neur	13
Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget	13
Acute motor deficit and subsequent remyelination‐associated recovery following internal capsule demyelination in mice	13
Stop the rot. Enzyme inactivation at brain harvest prevents artifacts	13
Endothelial cell biomarkers in critically ill COVID‐19 patients with encephalitis	13
Spinal Nrf2 translocation may inhibit neuronal NF‐κB activation and alleviate allodynia in a rat model of bone cancer pain	13
Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function	13
Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer’s disease	13
A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease	13
Lysine in the lariat loop of arrestins does not serve as phosphate sensor	12
Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease	12
α‐synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease	12
Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis	12
Pigment epithelium‐derived factor (PEDF) and derived peptides promote survival and differentiation of photoreceptors and induce neurite‐outgrowth in amacrine neurons	12
A multi‐omic analysis of the dorsal striatum in an animal model of divergent genetic risk for alcohol use disorder	12
ALS‐linked mutations impair UBQLN2 stress‐induced biomolecular condensate assembly in cells	12
Tau in the gut, does it really matter?	12
Extracellular ATP and cAMP signaling promote Piezo2‐dependent mechanical allodynia after trigeminal nerve compression injury	12
Impact of Wnt/β‐catenin signaling on ethanol‐induced changes in brain endothelial cell permeability	12
Artesunate restores mitochondrial fusion‐fission dynamics and alleviates neuronal injury in Alzheimer's disease models	12
Trajectory of change in brain complement factors from neonatal to young adult humans	12
Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease	12
Prefrontal cortex miR‐874‐3p prevents lipopolysaccharide‐induced depression‐like behavior through inhibition of indoleamine 2,3‐dioxygenase 1 expression in mice	12
Hericerin derivatives activates a pan‐neurotrophic pathway in central hippocampal neurons converging to ERK1/2 signaling enhancing spatial memory	12
MicroRNAs in oligodendrocyte development and remyelination	12
Diffusion kurtosis imaging detects the time‐dependent progress of pathological changes in the oral rotenone mouse model of Parkinson's disease	12
Shati/Nat8l deficiency disrupts adult neurogenesis and causes attentional impairment through dopaminergic neuronal dysfunction in the dentate gyrus	12
SUMOylation controls the neurodevelopmental function of the transcription factor Zbtb20	12
Cortical VIP+/ChAT+ interneurons: From genetics to function	12
Physiological involvement of presynaptic L‐type voltage‐dependent calcium channels in GABA release of cerebellar molecular layer interneurons	12
Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake	12
Antimicrobial protein REG3A and signaling networks are predictive of stroke outcomes	12
Biological and methodological complexities of beta‐amyloid peptide: Implications for Alzheimer’s disease research	12
Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals	11
Selective activation and down‐regulation of Trk receptors by neurotrophins in human neurons co‐expressing TrkB and TrkC	11
Role of dynein–dynactin complex, kinesins, motor adaptors, and their phosphorylation in dendritogenesis	11
Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils	11
Aminoacyl‐tRNA synthetases in Charcot–Marie–Tooth disease: A gain or a loss?	11
Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids	11
SARS‐CoV‐2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes	11
Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome	11
Ascorbate deficiency decreases dopamine release in gulo–/– and APP/PSEN1 mice	11
Andrographolide restores glucose uptake in rat hippocampal neurons	11
Do glia provide the link between low‐grade systemic inflammation and normal cognitive ageing? A 1H magnetic resonance spectroscopy study at 7 tesla	11
A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models	11
Heterogeneity of ferrous iron‐containing endolysosomes and effects of endolysosome iron on endolysosome numbers, sizes, and localization patterns	11
The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease	11
Serum neurofilament light chain and glial fibrillary acidic protein in AQP4‐IgG‐seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study	11
Mice deficient in the NAAG synthetase II gene Rimkla are impaired in a novel object recognition task	10
Palmitate‐mediated induction of neuropeptide Y expression occurs through intracellular metabolites and not direct exposure to proinflammatory cytokines	10
Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport	10
Genetically encoded fluorescent sensors for imaging neuronal dynamics in vivo	10
A neurobiological perspective on social influence: Serotonin and social adaptation	10
Glucose availability limits microglial nitric oxide production	10
Phosphorylation of Collapsin Response Mediator Protein 1 (CRMP1) at Tyrosine 504 residue regulates Semaphorin 3A‐induced cortical dendritic growth	10
Central cholinergic function and metabolic changes in streptozotocin‐induced rat brain injury	10
Suppression of tau‐induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity	10
Bile‐duct ligation renders the brain susceptible to hypotension‐induced neuronal degeneration: Implications of ammonia	10
Cerebrospinal fluid and serum protein markers in autism: A co‐twin study	10
Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy	10
Metabolic determinants of leukocyte pathogenicity in neurological diseases	10
Thioredoxin interacting protein drives astrocytic glucose hypometabolism in corticosterone‐induced depressive state	10
Androgen Receptor signaling promotes the neural progenitor cell pool in the developing cortex	10
LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons	10
In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions	10
Hyaluronidase inhibition accelerates functional recovery from stroke in the mouse brain	10
Activation of spinal PDGFRβ in microglia promotes neuronal autophagy via p38 MAPK pathway in morphine‐tolerant rats	10
Spontaneous, synchronous zinc spikes oscillate with neural excitability and calcium spikes in primary hippocampal neuron culture	10
The interplay between α7 nicotinic acetylcholine receptors, pannexin‐1 channels and P2X7 receptors elicit exocytosis in chromaffin cells	10
Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ)	10
SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration	10
A novel tri‐culture model for neuroinflammation	10
Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool	10
Cytisine is neuroprotective in female but not male 6‐hydroxydopamine lesioned parkinsonian mice and acts in combination with 17‐β‐estradiol to inhibit apoptotic endoplasmic reticulum stress in dopamin	10